Skip to main content

EDAP TMS S.A. (EDAP)

NASDAQ: EDAP · IEX Real-Time Price · USD
5.47 -0.02 (-0.27%)
Dec 8, 2021 4:00 PM EST - Market closed
Market Cap182.24M
Revenue (ttm)50.81M
Net Income (ttm)-2.08M
Shares Out33.35M
EPS (ttm)0.00
PE Ratio1,366.25
Forward PE27.55
Dividendn/a
Ex-Dividend Daten/a
Volume38,518
Open5.44
Previous Close5.48
Day's Range5.27 - 5.50
52-Week Range4.45 - 10.68
Beta1.54
AnalystsBuy
Price Target8.75 (+60.1%)
Earnings DateNov 17, 2021

About EDAP

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three divisions: High Intensity Focused Ultrasound (HIFU); Extracorporeal ShockWave Lithotripsy (ESWL); and Distribution. The HIFU division develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinic...

IndustryHealth Care Equipment & Supplies
IPO DateJul 31, 1997
Employees223
Stock ExchangeNASDAQ
Ticker SymbolEDAP
Full Company Profile

Financial Performance

Financial numbers in millions EURFinancial Statements

Analyst Forecast

According to 2 analysts, the average rating for EDAP TMS stock is "Buy." The 12-month stock price forecast is 8.75, which is an increase of 60.11% from the latest price.

Price Target
$8.75
(60.11% upside)
Analyst Consensus: Buy

News

EDAP to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

LYON, France, November 29, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the company will participate in a fireside chat a...

1 week ago - GlobeNewsWire

EDAP Reports Third Quarter 2021 Results and Provides Operational Update

LYON, France, November 17, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today unaudited financial results for the third quarter of 202...

3 weeks ago - GlobeNewsWire

EDAP TMS SA to Announce Third Quarter 2021 Financial Results on Wednesday, November 17, 2021

Company to host conference call and webcast on Thursday, November 18, at 8:30 am ET

4 weeks ago - GlobeNewsWire

EDAP Announces University of Washington Medicine to Launch Focal One® Robotic HIFU Program

Brings advanced focal ablation to prostate cancer patients in the Pacific Northwest

2 months ago - GlobeNewsWire

EDAP to Participate at Upcoming Investor Conferences

LYON, France, September 7, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), a global leader in robotic energy-based therapies, today announced that management will present at the following investor c...

3 months ago - GlobeNewsWire

EDAP Reports Second Quarter 2021 Results and Provides Operational Update

LYON, France, August 25, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today unaudited financial results for the second quarter of 2021...

3 months ago - GlobeNewsWire

EDAP Announces Select Preliminary Unaudited Second Quarter 2021 Results

LYON, France, August 4, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, reports today select preliminary unaudited second quarter financial and o...

4 months ago - GlobeNewsWire

EDAP Issues Letter to Shareholders

Successful financing and hiring of MedTech industry veteran Ryan Rhodes to drive accelerated U.S. expansion efforts

4 months ago - GlobeNewsWire

Recap: Edap TMS Q1 Earnings

Shares of Edap TMS (NASDAQ:EDAP) rose after the company reported Q1 results. Quarterly Results Earnings per share increased 160.00% year over year to $0.03, which beat the estimate of ($0.01).

6 months ago - Benzinga

EDAP Reports First Quarter 2021 Results and Provides Operational Update

LYON, France, May 11, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today unaudited financial results for the first quarter of 2021 and...

6 months ago - GlobeNewsWire

EDAP TMS SA to Announce First Quarter 2021 Financial Results on May 11, 2021

Company to host conference call and webcast on Wednesday , May 12 at 8:30 am EDT

7 months ago - GlobeNewsWire

EDAP Announces Pricing of Follow-On Offering

LYON, France, April 23, 2021 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced that the price of its offering of American Depositary Shares (“...

7 months ago - GlobeNewsWire

EDAP Announces Launch of Follow-On Offering

LYON, France, April 22, 2021 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today the launch of a follow-on public offering of its American...

7 months ago - GlobeNewsWire

Recap: Edap TMS Q4 Earnings

Shares of Edap TMS (NASDAQ:EDAP) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 175.00% over the past year to $0.03, which missed the ...

8 months ago - Benzinga

EDAP Reports Fourth Quarter 2020 Results and Provides Operational Update

LYON, France, March 30, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today unaudited financial results for the fourth quarter of 2020 ...

8 months ago - GlobeNewsWire

EDAP TMS S.A. (EDAP) Stock Jumps 18.8%: Will It Continue to Soar?

EDAP TMS S.A. (EDAP) was a big mover last session on higher-than-average trading volume.

8 months ago - Zacks Investment Research

A Preview Of Edap TMS's Earnings

Edap TMS (NASDAQ:EDAP) releases its next round of earnings this Tuesday, March 30. Here is Benzinga's essential guide to Edap TMS's Q4 earnings report.

8 months ago - Benzinga

EDAP Selects Leading Reimbursement Consultancies MTP and Argenta Advisors to Expand Market Access and Coverage of HIF...

EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, announces today that the company has selected Medical Technology Partners (MTP) and Argenta Advisors, two...

9 months ago - GlobeNewsWire

EDAP to Participate in B. Riley Securities Virtual Oncology Investor Conference

LYON, France, January 19, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, today announced that Marc Oczachowski, President and CEO, will particip...

10 months ago - GlobeNewsWire

EDAP Announces Positive 24 Month Interim Results of French Urology Association (AFU) Sponsored Clinical Study compari...

LYON, France, January 14, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, announced today positive 24 month interim results from the “HIFI” study...

10 months ago - GlobeNewsWire

EDAP TMS (EDAP) Surges: Stock Moves 6% Higher

EDAP TMS (EDAP) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

10 months ago - Zacks Investment Research

EDAP to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event

LYON, France, January 5, 2021 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, today announced that it will participate in the 10th Annual LifeSci Part...

11 months ago - GlobeNewsWire

EDAP Announces End of the Year Focal One® Sales

LYON, France, December 30, 2020 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy- based therapies, announced today two new Focal One sales to leading U.S. healthcare in...

11 months ago - GlobeNewsWire

EDAP Announces Final U.S. 2021 Reimbursement Rules for High Intensity Focused Ultrasound (HIFU)

Final rules establish, for the first time, a Category 1 CPT code and reimbursement to physicians performing ablation of malignant prostate tissue with HIFU in the US

11 months ago - GlobeNewsWire

Edap TMS: Q3 Earnings Insights

Shares of Edap TMS (NASDAQ:EDAP) were flat after the company reported Q3 results. Quarterly Results Earnings per share decreased 233.33% over the past year to ($0.04), which missed the estimate of ($0.02).

1 year ago - Benzinga